December 7, 2006

Elizabeth Nabel, MD
National Heart, Lung, and Blood Institute, NIH, DHHS

Congressman Tom Lantos
United States House of Representatives (D- California )

Congressman Kevin Brady
United States House of Representatives (R-Texas)

John H. Newman, MD, Vanderbilt University School of Medicine

Alfred P. Fishman, MD, University of Pennsylvania School of Medicine

History of PAH, Clinical Classification, and Risk and Prognostic Factors
Lewis J. Rubin, MD
University of California, San Diego

Current Therapy of Pulmonary Arterial Hypertension: Prostanoids, Endothelin Receptor Antagonists, and Phosphodiesterase Inhibitors
Robyn J. Barst, MD
Columbia University and Cornell Medical Center

The Potential Role of Combination Therapy in the Management of PAH
David B. Badesch, MD
University of Colorado School of Medicine

Break

Pathobiology of Pulmonary Hypertension
Rubin Tuder, MD
The Johns Hopkins University School of Medicine

Deficiency of Nitric oxide in Pulmonary Hypertension: Mechanisms and Consequences
Serpil C. Erzurum, MD
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

The Role of Angiopoietin-1/TIE2 in Pulmonary Hypertension
Patricia A. Thistlewaite, MD, PhD
University of California, San Diego

Why Severe Pulmonary Hypertension is so Difficult to Treat
Norbert F. Voelkel, MD
University of Colorado Health Sciences Center

Genetics of Pulmonary Hypertension: Role in Pathogenesis and Future Directions of Therapy
James E. Loyd, MD
Vanderbilt University School of Medicine

C. Gregory Elliott, MD, University of Utah, School of Medicine

Michael Solomon, MD, Critical Care Medicine Department, Clinical Center, NIH, DHHS

HIV Pathogenesis, Current Epidemiology, and Future Course
Henry Masur, MD
Critical Care Medicine Department, Clinical Center, NIH, DHHS

Pulmonary Arterial Hypertension in HIV Patients
Gerald Simonneau, MD
Clamart-University Paris, France

Mechanisms of Vasculopathy in Sickle Cell Disease
Gregory Kato, MD
National Heart, Lung, and Blood Institute, NIH, DHHS

Hemolysis-associated Pulmonary Hypertension
Roberto Machado, MD
National Heart, Lung, and Blood Institute, NIH, DHHS

Break

Chronic Thromboembolic Pulmonary Hypertension
Marius M. Hoeper, MD
University of Hanover Medical School, Germany

Pulmonary Hypertension Associated with Respiratory Disorders
Robert Naeije, MD, PhD
Free University of Brussels, Belgium

Pulmonary Hypertension Associated with Liver Disease
Michael Krowka, MD
Mayo College of Medicine

New Pathways to Pulmonary Hypertension and New Opportunities for Therapy
Marlene Rabinovitch, MD
Stanford University School of Medicine

Roberto Machado, MD
National Heart, Lung, and Blood Institute, NIH, DHHS

Poster Reception
Poster are attended.